The DSTYK Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt expression of the DSTYK gene in a near-haploid human cell background. This loss-of-function model enables systematic investigation of DSTYK biology without relying on single-cell clone isolation, offering a heterogeneous population that facilitates robust functional assays. By targeting DSTYK, researchers can interrogate its role in fibroblast growth factor (FGF) signaling pathways critical for cell proliferation and apoptosis regulation. The polyclonal format provides a versatile tool for high-throughput screens and mechanistic studies requiring consistent genetic ablation across the cell population.
HAP1 cells are derived from the KBM-7 chronic myeloid leukemia cell line and maintain a near-haploid karyotype, which simplifies genome-wide knockout strategies and reduces genetic redundancy. This host cell line is widely employed in functional genomics and genetic perturbation screens due to its stable haploid state, permitting unambiguous phenotype-genotype correlations. The HAP1 background supports efficient CRISPR/Cas9 editing and downstream analyses, making it an optimal platform for generating targeted gene disruptions like DSTYK knockout. Its characterized nature ensures reproducible signaling responses and cellular behaviors relevant to biomedical research.
DSTYK encodes a serine/threonine kinase that serves as a mediator of FGF signaling by physically interacting with the FGFR1 receptor and the adaptor protein FRS2. Upon FGF ligand stimulation, this complex recruits GRB2 and SOS, leading to RAS-RAF-MEK-ERK1/2 cascade activation and concomitant PI3K/AKT pathway engagement. Downstream effects include modulation of transcription factors and apoptotic regulators, thereby controlling cellular proliferation and survival. DSTYK thus functions as a node integrating signals from upstream FGF receptors to downstream ERK and AKT kinases, with interacting factors such as GRB2 and FRS2 facilitating signal propagation.
In the HAP1 context, disruption of DSTYK allows for precise dissection of its contribution to FGF-dependent phenotypes. The near-haploid nature minimizes compensatory effects from homologous gene copies, clarifying the direct consequences of DSTYK loss on MAPK/ERK and PI3K/AKT signaling axes. This model is particularly relevant for exploring pathogenic mechanisms underlying congenital anomalies of the kidney and urinary tract (CAKUT) and renal hypodysplasia, where DSTYK mutations are implicated. It provides a clean genetic background to evaluate how kinase-dead or null states affect apoptosis, proliferation, and differentiation programs in a reproducible manner.
Researchers can utilize this knockout population in a range of applications including functional genomics screens, drug target validation for CAKUT, and mechanistic studies of FGF-driven signaling. Typical assays involve western blotting for DSTYK and phospho-ERK/AKT, RT-qPCR of downstream targets, immunofluorescence localization, cell proliferation assays, and apoptosis detection via Annexin V staining under FGF stimulation. Co-immunoprecipitation experiments can further probe altered protein interactions within the FGFR1-FRS2-GRB2 complex. These polyclonal cells are a robust resource for advancing fundamental and translational research. For additional information or to inquire about bulk orders, please contact Ascent Research.
